Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
暂无分享,去创建一个
R. Tyndale | E. Sellers | Y. Rao | E. Hoffmann | Edward M Sellers | Rachel F Tyndale | Kerri A Schoedel | Ewa B Hoffmann | Yushu Rao | K. Schoedel | Yushu Rao
[1] M. Jarvik,et al. Nicotine Blood Levels and Subjective Craving for Cigarettes , 2000, Pharmacology Biochemistry and Behavior.
[2] K. Matsuo,et al. Association of CYP2A6 Gene Deletion with Cigarette Smoking Status in Japanese Adults , 2003, Journal of epidemiology.
[3] M. Ingelman-Sundberg,et al. Identification of a single nucleotide polymorphism in the TATA box of the CYP2A6 gene: impairment of its promoter activity. , 2001, Biochemical and biophysical research communications.
[4] Jennifer A. Ferguson,et al. Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependence. , 2003, Addictive behaviors.
[5] R. Tyndale,et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers , 2004, Tobacco Control.
[6] R. Tyndale,et al. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[7] S. Lai,et al. The Association Between Cigarette Smoking and Drug Abuse in the United States , 2000, Journal of addictive diseases.
[8] B. Green,et al. Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method. , 1999, Pharmacogenetics.
[9] J. Mackenbach,et al. Why do lower educated people continue smoking? Explanations from the longitudinal GLOBE study. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[10] R. Foxx,et al. Nicotine's role in smoking: an analysis of nicotine regulation. , 1983, Psychological bulletin.
[11] R. Tyndale,et al. Genotyping human CYP2A6 variants. , 2002, Methods in enzymology.
[12] R. Kessler,et al. Nicotine dependence in the United States: prevalence, trends, and smoking persistence. , 2001, Archives of general psychiatry.
[13] Jun Yokota,et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[14] M. Loriot,et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. , 2001, Pharmacogenetics.
[15] N. Martin,et al. The Genetics of Smoking Persistence in Men and Women: A Multicultural Study , 1999, Behavior genetics.
[16] D. Hamer,et al. An Improved Assay Shows No Association Between the CYP2A6 Gene and Cigarette Smoking Behavior , 1999 .
[17] S. Tokudome,et al. Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro , 2003, Clinical pharmacology and therapeutics.
[18] M. Djordjevic,et al. Nicotine regulates smoking patterns. , 1997, Preventive medicine.
[19] J. S. Miles,et al. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. , 1990, The Biochemical journal.
[20] M. Ingelman-Sundberg,et al. Characterisation and PCR‐based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population , 1999, FEBS letters.
[21] R. Tyndale,et al. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. , 2002, Biochemical and biophysical research communications.
[22] P. Batel,et al. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. , 1995, Addiction.
[23] M. Tsuang,et al. Genetic and environmental contributions to smoking. , 1997, Addiction.
[24] M. Mayo,et al. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. , 2002, JAMA.
[25] N E Morton,et al. The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit , 2000, Annals of human genetics.
[26] K Chiba,et al. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] R. Tyndale,et al. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. , 2000, Molecular pharmacology.
[28] C. Gevirtz,et al. Outcome and Six Month Follow Up of Patients After Ultra Rapid Opiate Detoxification (URODSM) , 2000, Journal of addictive diseases.
[29] K. Kendler,et al. Tobacco consumption in Swedish twins reared apart and reared together. , 2000, Archives of general psychiatry.
[30] R. Tyndale,et al. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking , 2000, Clinical pharmacology and therapeutics.
[31] R. Tyndale,et al. Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.
[32] O Pelkonen,et al. Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism , 1999, FEBS letters.
[33] S. Anttila,et al. Expression of CYP2A genes in human liver and extrahepatic tissues. , 1999, Biochemical pharmacology.
[34] M. Kitagawa,et al. CYP2A6*6, a Novel Polymorphism in Cytochrome P450 2A6, Has a Single Amino Acid Substitution (R128Q) That Inactivates Enzymatic Activity* , 2001, The Journal of Biological Chemistry.
[35] K. Iwahashi,et al. Whole Deletion of CYP2A6 Gene (CYP2A6*4C) and Smoking Behavior , 2004, Neuropsychobiology.
[36] Y. Funae,et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[37] P. Gahlinger,et al. Computer Programs for Epidemiologists: Pepi Version 4.0 , 2001 .
[38] M. Nakajima,et al. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. , 2002, British journal of clinical pharmacology.
[39] S. Fujishima,et al. Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema , 2003, Thorax.
[40] R. Tyndale,et al. Assessment of nicotine dependence symptoms in adolescents: a comparison of five indicators. , 2002, Tobacco control.
[41] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.
[42] R. Tyndale,et al. Mimicking Gene Defects to Treat Drug Dependence , 2000, Annals of the New York Academy of Sciences.
[43] R. Tyndale,et al. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. , 1997, The Journal of pharmacology and experimental therapeutics.
[44] M. Ingelman-Sundberg,et al. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity , 2002, Human mutation.
[45] J. Kugler,et al. Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. , 2003, The American journal of psychiatry.
[46] N. Benowitz,et al. Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. , 1989, Progress in brain research.
[47] Hiroshi Yamamoto,et al. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans , 2001, Clinical pharmacology and therapeutics.
[48] N. Benowitz,et al. Metabolism of nicotine to cotinine studied by a dual stable isotope method , 1994, Clinical pharmacology and therapeutics.
[49] H. Yamazaki,et al. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians , 2000, Archives of Toxicology.
[50] P. Fernández-Salguero,et al. The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. , 1995, Pharmacogenetics.
[51] G. Bepler,et al. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method. , 2001, Toxicology.
[52] T. Kamataki,et al. Predicting the mutagenicity of tobacco‐related N‐nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH–cytochrome P450 reductase , 2001, Environmental and molecular mutagenesis.